For the Leaders

leadership

Article

Where Is The Money Going? Tracking Biotech AI Seed Funding In Cancer Research

AI cancer seed funding is surging despite a tighter market. Here's where the money flows, who backs it, and wh...

A Founder’s Guide To Computational Chemistry Platforms For Early-Stage Oncology Startups
A Founder’s Guide To Computational Chemistry Platforms For Early-Stage Oncology Startups

Simantini Singh Deo | Jun 04, 2026

FDA Computer Software Assurance (CSA): A Definitive Guide for Pharma Leaders
FDA Computer Software Assurance (CSA): A Definitive Guide for Pharma Leaders

Mrudula Kulkarni | May 25, 2026

How To Prepare For A Remote Audit: A Step-by-Step Guide
How To Prepare For A Remote Audit: A Step-by-Step Guide

Simantini Singh Deo | May 21, 2026

Other latest content for leaders you may like to read

Where Is The Money Going? Tracking Biotech AI Seed Funding In Cancer Research

AI cancer seed funding is surging despite a tighter market. Here's where the money flows, who backs it, and what the bets signal for pharma.

by Simantini Singh Deo
Pharma Now

A Founder’s Guide To Computational Chemistry Platforms For Early-Stage Oncology Startups

How oncology startups can use computational chemistry platforms to speed up drug discovery, cut costs, and make smarter research decisions

by Simantini Singh Deo
Pharma Now

FDA Computer Software Assurance (CSA): A Definitive Guide for Pharma Leaders

FDA Computer Software Assurance explained, CSA vs CSV, six step framework, SaaS validation and implementation roadmap for pharma leaders.

by Mrudula Kulkarni
Pharma Now

How To Prepare For A Remote Audit: A Step-by-Step Guide

Remote audit prep: 6-step checklist for coordination, documents, digital tools, team training, equipment and compliance verification.

by Simantini Singh Deo
Pharma Now

The LIMS Decision: Why Your Laboratory Software Choice Is Now a Regulatory and Strategic Imperative

As FDA enforcement tightens, your LIMS choice is no longer an IT call — it's a quality decision with boardroom consequences.

by Ravindra Warang
Pharma Now